333 related articles for article (PubMed ID: 24472843)
1. Cilostazol attenuates ischemia-reperfusion-induced blood-brain barrier dysfunction enhanced by advanced glycation endproducts via transforming growth factor-β1 signaling.
Takeshita T; Nakagawa S; Tatsumi R; So G; Hayashi K; Tanaka K; Deli MA; Nagata I; Niwa M
Mol Cell Neurosci; 2014 May; 60():1-9. PubMed ID: 24472843
[TBL] [Abstract][Full Text] [Related]
2. Cilostazol strengthens barrier integrity in brain endothelial cells.
Horai S; Nakagawa S; Tanaka K; Morofuji Y; Couraud PO; Deli MA; Ozawa M; Niwa M
Cell Mol Neurobiol; 2013 Mar; 33(2):291-307. PubMed ID: 23224787
[TBL] [Abstract][Full Text] [Related]
3. Advanced glycation end-products disrupt the blood-brain barrier by stimulating the release of transforming growth factor-β by pericytes and vascular endothelial growth factor and matrix metalloproteinase-2 by endothelial cells in vitro.
Shimizu F; Sano Y; Tominaga O; Maeda T; Abe MA; Kanda T
Neurobiol Aging; 2013 Jul; 34(7):1902-12. PubMed ID: 23428182
[TBL] [Abstract][Full Text] [Related]
4. Baicalin reduces the permeability of the blood-brain barrier during hypoxia in vitro by increasing the expression of tight junction proteins in brain microvascular endothelial cells.
Zhu H; Wang Z; Xing Y; Gao Y; Ma T; Lou L; Lou J; Gao Y; Wang S; Wang Y
J Ethnopharmacol; 2012 Jun; 141(2):714-20. PubMed ID: 21920425
[TBL] [Abstract][Full Text] [Related]
5. Candesartan improves ischemia-induced impairment of the blood-brain barrier in vitro.
So G; Nakagawa S; Morofuji Y; Hiu T; Hayashi K; Tanaka K; Suyama K; Deli MA; Nagata I; Matsuo T; Niwa M
Cell Mol Neurobiol; 2015 May; 35(4):563-72. PubMed ID: 25547389
[TBL] [Abstract][Full Text] [Related]
6. Cilostazol inhibits the redistribution of the actin cytoskeleton and junctional proteins on the blood-brain barrier under hypoxia/reoxygenation.
Torii H; Kubota H; Ishihara H; Suzuki M
Pharmacol Res; 2007 Feb; 55(2):104-10. PubMed ID: 17157525
[TBL] [Abstract][Full Text] [Related]
7. A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes.
Nakagawa S; Deli MA; Kawaguchi H; Shimizudani T; Shimono T; Kittel A; Tanaka K; Niwa M
Neurochem Int; 2009; 54(3-4):253-63. PubMed ID: 19111869
[TBL] [Abstract][Full Text] [Related]
8. Cilostazol ameliorates ischemia/reperfusion-induced tight junction disruption in brain endothelial cells by inhibiting endoplasmic reticulum stress.
Nan D; Jin H; Deng J; Yu W; Liu R; Sun W; Huang Y
FASEB J; 2019 Sep; 33(9):10152-10164. PubMed ID: 31184927
[TBL] [Abstract][Full Text] [Related]
9. Effects of fasudil on blood-brain barrier integrity.
Sato K; Nakagawa S; Morofuji Y; Matsunaga Y; Fujimoto T; Watanabe D; Izumo T; Niwa M; Walter FR; Vigh JP; Santa-Maria AR; Deli MA; Matsuo T
Fluids Barriers CNS; 2022 Jun; 19(1):43. PubMed ID: 35659272
[TBL] [Abstract][Full Text] [Related]
10. Hyperglycaemia promotes cerebral barrier dysfunction through activation of protein kinase C-β.
Shao B; Bayraktutan U
Diabetes Obes Metab; 2013 Nov; 15(11):993-9. PubMed ID: 23617822
[TBL] [Abstract][Full Text] [Related]
11. Effects of the chemokine CCL2 on blood-brain barrier permeability during ischemia-reperfusion injury.
Dimitrijevic OB; Stamatovic SM; Keep RF; Andjelkovic AV
J Cereb Blood Flow Metab; 2006 Jun; 26(6):797-810. PubMed ID: 16192992
[TBL] [Abstract][Full Text] [Related]
12. Transient oxygen-glucose deprivation sensitizes brain capillary endothelial cells to rtPA at 4h of reoxygenation.
Kuntz M; Mysiorek C; Pétrault O; Boucau MC; Aijjou R; Uzbekov R; Bérézowski V
Microvasc Res; 2014 Jan; 91():44-57. PubMed ID: 24333620
[TBL] [Abstract][Full Text] [Related]
13. Maintaining blood-brain barrier integrity: pericytes perform better than astrocytes during prolonged oxygen deprivation.
Al Ahmad A; Gassmann M; Ogunshola OO
J Cell Physiol; 2009 Mar; 218(3):612-22. PubMed ID: 19016245
[TBL] [Abstract][Full Text] [Related]
14. Hypertonic saline alleviates experimentally induced cerebral oedema through suppression of vascular endothelial growth factor and its receptor VEGFR2 expression in astrocytes.
Huang L; Cao W; Deng Y; Zhu G; Han Y; Zeng H
BMC Neurosci; 2016 Oct; 17(1):64. PubMed ID: 27733124
[TBL] [Abstract][Full Text] [Related]
15. Effects of erythropoietin on blood-brain barrier tight junctions in ischemia-reperfusion rats.
Liu K; Sun T; Wang P; Liu YH; Zhang LW; Xue YX
J Mol Neurosci; 2013 Feb; 49(2):369-79. PubMed ID: 23001813
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta signaling alters substrate permeability and tight junction protein expression at the blood-brain barrier during inflammatory pain.
Ronaldson PT; Demarco KM; Sanchez-Covarrubias L; Solinsky CM; Davis TP
J Cereb Blood Flow Metab; 2009 Jun; 29(6):1084-98. PubMed ID: 19319146
[TBL] [Abstract][Full Text] [Related]
17. The molecular mechanism and effect of cannabinoid-2 receptor agonist on the blood-spinal cord barrier permeability induced by ischemia-reperfusion injury.
Yang MC; Zhang HZ; Wang Z; You FL; Wang YF
Brain Res; 2016 Apr; 1636():81-92. PubMed ID: 26835555
[TBL] [Abstract][Full Text] [Related]
18. A pericyte-derived angiopoietin-1 multimeric complex induces occludin gene expression in brain capillary endothelial cells through Tie-2 activation in vitro.
Hori S; Ohtsuki S; Hosoya K; Nakashima E; Terasaki T
J Neurochem; 2004 Apr; 89(2):503-13. PubMed ID: 15056293
[TBL] [Abstract][Full Text] [Related]
19. Cerebral hypoxia/ischemia selectively disrupts tight junctions complexes in stem cell-derived human brain microvascular endothelial cells.
Page S; Munsell A; Al-Ahmad AJ
Fluids Barriers CNS; 2016 Oct; 13(1):16. PubMed ID: 27724968
[TBL] [Abstract][Full Text] [Related]
20. Ligustilide Ameliorates the Permeability of the Blood-Brain Barrier Model In Vitro During Oxygen-Glucose Deprivation Injury Through HIF/VEGF Pathway.
Wu S; Wang N; Li J; Wang G; Seto SW; Chang D; Liang H
J Cardiovasc Pharmacol; 2019 May; 73(5):316-325. PubMed ID: 30855407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
